Provided by Tiger Trade Technology Pte. Ltd.

Inovio Pharmaceuticals

1.18
-0.0300-2.48%
Post-market: 1.190.0099+0.84%19:59 EDT
Volume:5.02M
Turnover:5.94M
Market Cap:121.54M
PE:-1.14
High:1.24
Open:1.23
Low:1.15
Close:1.21
52wk High:2.98
52wk Low:0.5632
Shares:103.00M
Float Shares:95.79M
Volume Ratio:0.73
T/O Rate:5.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0338
EPS(LYR):-1.8117
ROE:-409.87%
ROA:-84.23%
PB:27.81
PE(LYR):-0.65

Loading ...

Oct 29, 2021

Major Issues Report

8-K - Current report
Oct 28, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 11, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 01, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 01, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 22, 2021

Major Issues Report

8-K - Current report
Jan 22, 2021

Major Issues Report

8-K - Current report
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 04, 2021

Major Issues Report

8-K - Current report
Nov 16, 2020

Major Issues Report

8-K - Current report